Literature DB >> 35895586

Association between Antimicrobial Consumption and the Prevalence of Nosocomial Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae in a Tertiary Hospital in Northern Taiwan.

Mei-Chun Lee1,2, Hsun Chang3, Fang-Ju Sun2,4, Alice Ying-Jung Wu3, Chien-Hung Lu1, Chun-Ming Lee2,3,5,6.   

Abstract

Carbapenem-resistant Enterobacteriales has become a threat in Taiwan. This is the first local study focusing on the association between carbapenem-resistant Enterobacteriales and antimicrobial consumption. From January 2012 to December 2020, data were collected in a tertiary care hospital in Taipei, Taiwan. Antimicrobial consumption was estimated by the defined daily dose/1,000 patient-days. During the same period, the prevalence of carbapenem-resistant Escherichia coli (CREC) and carbapenem-resistant Klebsiella pneumoniae (CRKP) were collected through routine surveillance data. The following retrospective analyses were conducted: 1) analysis of antimicrobial consumption over time, (2) analysis and forecast of CREC and CRKP prevalence over time, and 3) analysis of correlation between antimicrobial consumption and the prevalence of CREC and CRKP. The consumption of piperacillin/tazobactam (β = 0.615), fluoroquinolones (β = 0.856), meropenem (β = 0.819), and doripenem (β = 0.891) increased during the observation period (P < 0.001), and the consumption of aminoglycosides (β = -0.852) and imipenem/cilastatin (β = -0.851) decreased (P < 0.001). The prevalence of CRKP rose over time (β = 0.522, P = 0.001) and correlated positively with the consumption of fluoroquinolones, levofloxacin, penicillin/β-lactamase inhibitor, piperacillin/tazobactam, meropenem, and doripenem (P < 0.05). The prevalence of CRKP and CREC both correlated negatively with consumption of aminoglycosides (P < 0.01). The prevalence of CRKP in our hospital increased as the forecast predicted based on an autoregressive integrated moving average model. This study provides alarming messages for members participating in antimicrobial stewardship programs, including the increasing prevalence of CRKP, the increasing consumption of broad-spectrum antibiotics, and the positive correlation between them.

Entities:  

Year:  2022        PMID: 35895586      PMCID: PMC9393431          DOI: 10.4269/ajtmh.21-1242

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  34 in total

1.  The World Health Organization Global Action Plan for antimicrobial resistance.

Authors:  Marc Mendelson; Malebona Precious Matsoso
Journal:  S Afr Med J       Date:  2015-04-06

2.  Evaluation of patient risk factors for infection with carbapenem-resistant Enterobacteriaceae.

Authors:  Marko Predic; John P Delano; Elizabeth Tremblay; Nicole Iovine; Scott Brown; Cindy Prins
Journal:  Am J Infect Control       Date:  2020-01-08       Impact factor: 2.918

3.  Risk factors and mortality in the Carbapenem-resistant Klebsiella pneumoniae infection: case control study.

Authors:  Fethiye Akgul; Ilkay Bozkurt; Mustafa Sunbul; Saban Esen; Hakan Leblebicioglu
Journal:  Pathog Glob Health       Date:  2016-12-01       Impact factor: 2.894

4.  Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.

Authors:  Marie-Hélène Nicolas-Chanoine; Marie Vigan; Cédric Laouénan; Jérôme Robert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-11-28       Impact factor: 3.267

5.  The risk of seizures among the carbapenems: a meta-analysis.

Authors:  Joan P Cannon; Todd A Lee; Nina M Clark; Paul Setlak; Shellee A Grim
Journal:  J Antimicrob Chemother       Date:  2014-04-16       Impact factor: 5.790

Review 6.  The negative impact of antibiotic resistance.

Authors:  N D Friedman; E Temkin; Y Carmeli
Journal:  Clin Microbiol Infect       Date:  2015-12-17       Impact factor: 8.067

7.  Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.

Authors:  Ping Yang; Yunbo Chen; Saiping Jiang; Ping Shen; Xiaoyang Lu; Yonghong Xiao
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-19       Impact factor: 4.887

8.  Antimicrobial resistance surveillance and prediction of Gram-negative bacteria based on antimicrobial consumption in a hospital setting: A 15-year retrospective study.

Authors:  Wei Guo; Fengjun Sun; Fang Liu; Liya Cao; Jie Yang; Yongchuan Chen
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 9.  Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance.

Authors:  L R Peterson
Journal:  Clin Microbiol Infect       Date:  2005-10       Impact factor: 8.067

10.  Distribution of fluoroquinolone resistance determinants in Carbapenem-resistant Klebsiella pneumoniae clinical isolates associated with bloodstream infections in China.

Authors:  Qing Zhan; Yanlei Xu; Bingjie Wang; Jingyi Yu; Xiaofei Shen; Li Liu; Xingwei Cao; Yinjuan Guo; Fangyou Yu
Journal:  BMC Microbiol       Date:  2021-06-02       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.